These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 7650576)
1. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients. McCullough M; Hume S J Med Vet Mycol; 1995; 33(1):33-7. PubMed ID: 7650576 [TBL] [Abstract][Full Text] [Related]
2. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis]. Ruhnke M; Tennagen I; Engelmann E Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368 [TBL] [Abstract][Full Text] [Related]
3. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV]. Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757 [TBL] [Abstract][Full Text] [Related]
4. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A; J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125 [TBL] [Abstract][Full Text] [Related]
5. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689 [TBL] [Abstract][Full Text] [Related]
6. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956 [TBL] [Abstract][Full Text] [Related]
7. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients. Maninder J; Usha A J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients. Woldeamanuel Y; Abate D Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299 [TBL] [Abstract][Full Text] [Related]
9. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest]. Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812 [TBL] [Abstract][Full Text] [Related]
10. [Fluconazole sensitivity of Candida strains in vitro in the microdilution test and agar diffusion test]. Metzger S; Jäger H; Hofmann H Mycoses; 1994; 37 Suppl 1():64-70. PubMed ID: 7854369 [TBL] [Abstract][Full Text] [Related]
11. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance. Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273 [TBL] [Abstract][Full Text] [Related]
12. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model. Reynes J; Mallie M; Ravisse P; Bastide JM J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537 [TBL] [Abstract][Full Text] [Related]
13. [Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method]. Qian J; Zha GZ; Yu P Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):327-30. PubMed ID: 12205990 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
15. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530 [TBL] [Abstract][Full Text] [Related]
16. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667 [TBL] [Abstract][Full Text] [Related]
17. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients. Chryssanthou E; Torssander J; Petrini B Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076 [TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of long-term colonization of Candida albicans strains from HIV-infected patients. Li SY; Yang YL; Chen KW; Cheng HH; Chiou CS; Wang TH; Lauderdale TL; Hung CC; Lo HJ Epidemiol Infect; 2006 Apr; 134(2):265-9. PubMed ID: 16490129 [TBL] [Abstract][Full Text] [Related]
19. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. Johnson EM; Warnock DW; Luker J; Porter SR; Scully C J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758 [TBL] [Abstract][Full Text] [Related]
20. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis. Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]